Phaos Technology Holdings (Cayman) (POAS) Liabilities and Shareholders Equity (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Liabilities and Shareholders Equity came in at $992019.9 in Q4 2025, down 31.44% on a QoQ basis from $1.4 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $992019.9 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 4.24 Mn | 4.20 Mn | - | 992,019.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 992,019.92 |
| Apr 30, 2025 | 1.45 Mn |
| Apr 30, 2024 | 3.85 Mn |